Center of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, Jiangsu 210009, PR China.
Phytother Res. 2012 Jan;26(1):118-21. doi: 10.1002/ptr.3522. Epub 2011 May 12.
This article studied the possible effect of rifampicin (RIF), an inhibitor of organic anion transporting polypeptide (Oatp), on the pharmacokinetics of salvianolic acid B (SAB) in rats. Rifampicin was administered intravenously 15 min prior to SAB (5 mg/kg) in rats at doses of 0, 5.0, 10.0 and 20.0 mg/kg, respectively. The concentrations of SAB in plasma and bile were determined using a Shimadzu HPLC system coupled to a LC-MS-2010EV mass spectrometer. Compared with the control group, the AUC(0-t) and C(max) values of SAB were increased significantly, while the CL(total) and CL(bile) were decreased significantly. These results suggested that pretreatment with rifampicin prior to SAB administration could decrease significantly the total and bile elimination of SAB and alter its pharmacokinetic profiles. The influence of rifampicin on the pharmacokinetics of SAB may be attributed to the inhibition of Oatp-mediated influx.
本文研究了有机阴离子转运多肽(Oatp)抑制剂利福平(RIF)对大鼠体内丹酚酸 B(SAB)药代动力学的可能影响。在分别给予 0、5.0、10.0 和 20.0mg/kg 的利福平 15 分钟后,静脉内给予大鼠 5mg/kg 的 SAB。采用 Shimadzu HPLC 系统与 LC-MS-2010EV 质谱联用,测定血浆和胆汁中 SAB 的浓度。与对照组相比,SAB 的 AUC(0-t)和 C(max)值显著增加,而 CL(total)和 CL(bile)值显著降低。这些结果表明,在给予 SAB 之前用利福平预处理可显著降低 SAB 的总消除率和胆汁消除率,并改变其药代动力学特征。利福平对 SAB 药代动力学的影响可能归因于抑制 Oatp 介导的摄取。